TraceyMcLaughlinMDMS
Endocrinology • Stanford, CADiabetes, Lipid Metabolism
Professor, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University Medical Center
Dr. McLaughlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- I am a board certified endocrinologist with a sub-specialization in diabetes and metabolism. I see patients with type 1 and type 2 diabetes as well as hypoglycemia, polycystic ovary syndrome, and metabolic syndrome. I conduct clinical research on obesity, diabetes, and metabolism.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
Santa Clara Valley Medical CenterResidency, Internal Medicine, 1994 - 1997
University of California San Francisco School of MedicineClass of 1994
University of California, BerkeleyMS, Public Health, 1991 - 1992
Certifications & Licensure
CA State Medical License 1995 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Obesity, Weight Loss, and Cardiovascular Disease Risk Start of enrollment: 2000 Oct 01
- Integrating the Genetic and Metabolic Faces of Obesity Start of enrollment: 2005 Oct 01
- Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive Humans Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsHyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.Nadine Nagy, Vivekananda Gupta Sunkari, Gernot Kaber, Sonia Hasbun, Dung N. Lam
Matrix Biology. 2019-07-01 - 59 citationsThe receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissueLi-Fen Liu, Keiichi Kodama, Ke Wei, Lorna L. Tolentino, Okmi Choi
Diabetologia. 2015-05-09 - 1 citationsInhibition of hyaluronan synthesis prevents β-cell loss in obesity-associated type 2 diabetes.Nadine Nagy, Gernot Kaber, Vivekananda G Sunkari, Payton L Marshall, Aviv Hargil
Matrix Biology. 2023-11-01
Journal Articles
- Metabolic Markers, Regional Adiposity, and Adipose Cell Size: Relationship to Insulin Resistance in African-American as Compared with Caucasian WomenTracey McLaughlin, MD, Nature
- Hypoglycemia After Gastric Bypass Surgery: Current Concepts and ControversiesTracey McLaughlin, Adrian Vella, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
SARS-CoV-2 Can Infect Fat Cells, Promoting Infection & InflammationOctober 13th, 2022- SARS-CoV-2 Infects Fat Tissue and Creates InflammationSeptember 27th, 2022
- The Coronavirus Infects Fat Cells, Study ShowsSeptember 23rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
